Fed. Circ. Clips Exela Appeal In Ofirmev Infringement Row
The Federal Circuit on Monday upheld a Delaware federal judge's ruling that Exela Pharma Sciences LLC and two related entities flouted two Cadence Pharmaceuticals Inc. patents covering the injectable pain reliever...To view the full article, register now.
Already a subscriber? Click here to view full article